Non-steroidal Anti-inflammation Drugs can effectively reduce the lower urinary tract symptoms from benign prostatic hyperplasia
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Continued medication that the patient had before the enrollment of this study (tamsulosin 0.2mg, alfuzosin 10mg, doxazosin 4, 8mg, or terazosin 2-10mg daily for 8 weeks)
200mg daily for 8 weeks
amsulosin 0.2mg, alfuzosin 10mg, doxazosin 4, 8mg, or terazosin 2-10mg daily for 8 weeks and celecoxib 200mg daily for 8 weeks
Severance Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
The changes of International Prostatic Symptom Scores after medications
Time frame: 8 weeks
The changes of voiding frequencies after medications
Time frame: 8 weeks
The changes of 'ICS male questionnaire-short form' after medications
Time frame: 8 weeks
Patient perception of treatment benefit questionnaire
Time frame: 8 weeks
The changes of 'patient perception of bladder condition' after medications
Time frame: 8 weeks
The changes of maximum flow rate and postvoid residuals after medications
Time frame: 8 weeks
The changes of serum PSA levels after medications
Time frame: 8 weeks
The changes of WBC counts on the expressed prostatic secretions after medications
Time frame: 8 weeks
Complications
Time frame: During all study periods
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.